Does DURVALUMAB Cause Hyperglycaemia? 52 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 52 reports of Hyperglycaemia have been filed in association with DURVALUMAB (IMFINZI). This represents 0.3% of all adverse event reports for DURVALUMAB.
52
Reports of Hyperglycaemia with DURVALUMAB
0.3%
of all DURVALUMAB reports
13
Deaths
29
Hospitalizations
How Dangerous Is Hyperglycaemia From DURVALUMAB?
Of the 52 reports, 13 (25.0%) resulted in death, 29 (55.8%) required hospitalization, and 13 (25.0%) were considered life-threatening.
Is Hyperglycaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DURVALUMAB. However, 52 reports have been filed with the FAERS database.
What Other Side Effects Does DURVALUMAB Cause?
Death (2,817)
Malignant neoplasm progression (1,330)
Pneumonitis (827)
Radiation pneumonitis (786)
Pyrexia (573)
Diarrhoea (530)
Pneumonia (453)
Dyspnoea (444)
Interstitial lung disease (430)
Off label use (395)
What Other Drugs Cause Hyperglycaemia?
INSULIN GLARGINE (1,903)
METFORMIN (1,626)
ALPELISIB (1,575)
DEXAMETHASONE (1,169)
PREDNISONE (1,135)
INSULIN LISPRO (743)
PREDNISOLONE (705)
INSULIN ASPART (646)
INSULIN HUMAN (620)
METHYLPREDNISOLONE (604)
Which DURVALUMAB Alternatives Have Lower Hyperglycaemia Risk?
DURVALUMAB vs DUTASTERIDE
DURVALUMAB vs DUTASTERIDE\TAMSULOSIN
DURVALUMAB vs DUVELISIB
DURVALUMAB vs DYDROGESTERONE
DURVALUMAB vs EBASTINE